Lintzeris, Nicholas

Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial

Allsop, D. J., Copeland, J., Lintzeris, N., Dunlop, A. J., Montebello, M., Sadler, C., Rivas, G. R., Holland, R. M., Muhleisen, P., Norberg, M. M., et al. (2014) · JAMA Psychiatry

Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and Outcomes

Cited by 266

Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis

Nielsen, S., Sabioni, P., Trigo, J. M., Ware, M. A., Betz-Stablein, B. D., Murnion, B., Lintzeris, N., Khor, K. E., Farrell, M., Smith, A., et al. (2017) · Neuropsychopharmacology

Cannabis and Cannabinoid ResearchPain Management and Opioid Use

Cited by 265

Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review

Siefried, K. J., Acheson, L. S., Lintzeris, N., & Ezard, N. (2020) · CNS Drugs

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 194

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

Grimison, P., Mersiades, A., Kirby, A., Lintzeris, N., Morton, R., Haber, P., Olver, I., Walsh, A., McGregor, I., Cheung, Y., et al. (2020) · Annals of Oncology

Nausea and vomiting managementCannabis and Cannabinoid Research

Cited by 162

Benzodiazepine Use among Chronic Pain Patients Prescribed Opioids: Associations with Pain, Physical and Mental Health, and Health Service Utilization

Nielsen, S., Lintzeris, N., Bruno, R., Campbell, G., Larance, B., Hall, W., Hoban, B., Cohen, M. L., & Degenhardt, L. (2015) · Pain Medicine

Opioid Use Disorder TreatmentPain Management and Opioid Use

Cited by 131

Medicinal cannabis in Australia, 2016: the Cannabis as Medicine Survey (CAMS-16)

Lintzeris, N., Driels, J., Elias, N., Arnold, J. C., McGregor, I. S., & Allsop, D. J. (2018) · Medical Journal of Australia

Cannabis and Cannabinoid ResearchComplementary and Alternative Medicine Studies

Cited by 101

Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia?

NIELSEN, S., BRUNO, R., LINTZERIS, N., FISCHER, J., CARRUTHERS, S., & STOOVÉ, M. (2011) · Drug and Alcohol Review

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 35

Transferring Patients From Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines

Lintzeris, N., Monds, L. A., Rivas, C., Leung, S., Dunlop, A., Newcombe, D., Walters, C., Galea, S., White, N., Montebello, M., et al. (2018) · Journal of Addiction Medicine

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 34

Urinary cannabinoid levels during nabiximols (Sativex®)-medicated inpatient cannabis withdrawal.

Kevin, R. C., Allsop, D. J., Lintzeris, N., Dunlop, A. J., Booth, J., & McGregor, I. S. (2017) · Forensic Toxicology

Cannabis and Cannabinoid ResearchForensic Toxicology and Drug Analysis

Cited by 24

A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol

Bhardwaj, A. K., Mills, L., Doyle, M., Sahid, A., Montebello, M., Monds, L., Arunogiri, S., Haber, P., Lorenzetti, V., Lubman, D. I., et al. (2024) · BMC Psychiatry

Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and Outcomes

Cited by 10